Insider Transactions in Q2 2022 at Crinetics Pharmaceuticals, Inc. (CRNX)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 20
2022
|
Stephen F. Betz Chief Scientific Officer |
BUY
Other acquisition or disposition
|
Direct |
1,336
+1.21%
|
$14,696
$11.02 P/Share
|
|
May 20
2022
|
Jeff E. Knight Chief Operating Officer |
BUY
Other acquisition or disposition
|
Direct |
1,152
+15.88%
|
$19,584
$17.44 P/Share
|
|
May 02
2022
|
Stephen F. Betz Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,247
-2.93%
|
$64,940
$20.1 P/Share
|
|
Apr 18
2022
|
Stephen F. Betz Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,664
-4.86%
|
$141,600
$25.81 P/Share
|
|
Apr 18
2022
|
Perceptive Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
157,515
+2.88%
|
$3,465,330
$22.22 P/Share
|
|
Apr 13
2022
|
Richard Scott Struthers President & CEO |
SELL
Open market or private sale
|
Indirect |
138,643
-5.6%
|
$3,604,718
$26.49 P/Share
|
|
Apr 05
2022
|
Richard Scott Struthers President & CEO |
SELL
Open market or private sale
|
Indirect |
21,357
-2.4%
|
$533,925
$25.34 P/Share
|
|
Apr 04
2022
|
Stephen F. Betz Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
9,000
-7.17%
|
$207,000
$23.97 P/Share
|
|
Apr 01
2022
|
Stephen F. Betz Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,164
-3.21%
|
$87,444
$21.8 P/Share
|